Results 231 to 240 of about 4,398,820 (307)

Group Poetry and Quilt-Making -Creative Public Involvement Approaches to Contentious Concepts in Frailty Research. [PDF]

open access: yesHealth Expect
Lammons W   +10 more
europepmc   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

open access: yesMolecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder   +10 more
wiley   +1 more source

Automated assessment of echocardiograms to aid diagnosis of heart failure with preserved ejection fraction. [PDF]

open access: yesEur Heart J Digit Health
Venema CS   +17 more
europepmc   +1 more source

Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial. [PDF]

open access: yesCancer
Stacchiotti S   +31 more
europepmc   +1 more source

Automated Multienzyme Digestion Workflows for Confident Characterization of Challenging Posttranslational Modifications in Therapeutic Antibodies by LC-MS/MS. [PDF]

open access: yesRapid Commun Mass Spectrom
Eskesen NS   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy